99% Savings - Buy Just @1 Rs X
Halovate F Cream 10gm is a commercial drug that is prescribed in the form of Cream. Primarily, it is used for the treatment of Dermatitis. Other than this, Halovate F Cream 10gm has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Halovate F Cream 10gm is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Some other side effects of Halovate F Cream 10gm have been listed ahead. Normally, these side effects of Halovate F Cream 10gm are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Halovate F Cream 10gm has a Moderate effect for pregnant women and Mild effect on lactating mothers. In addition, Halovate F Cream 10gm's effects on the liver, heart and kidney are discussed below in the Halovate F Cream 10gm related warnings section.
Some other conditions that can be affected by Halovate F Cream 10gm are listed in the contraindications section below.
Drug reaction of Halovate F Cream 10gm with other medicines has been reported. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Halovate F Cream 10gm is considered safe while driving, and is addictive.
Halovate F Cream 10gm is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
Is the use of Halovate F Cream 10gm safe for pregnant women?
Halovate can have harmful effects in pregnant women. If you experience any discomfort after using Halovate, then discontinue the use and take your doctor's advice.
Is the use of Halovate F Cream 10gm safe during breastfeeding?
Halovate may have very limited harmful effects for breastfeeding women.
What is the effect of Halovate F Cream 10gm on the Kidneys?
There are no side effects of Halovate on the kidneys.
What is the effect of Halovate F Cream 10gm on the Liver?
Using Halovate does not have any harmful effects on the liver.
What is the effect of Halovate F Cream 10gm on the Heart?
Using Halovate does not have any harmful effects on the heart.
Halovate F Cream 10gm should not be taken with following medicines due to severe side effects it may cause to patients -
Mild
If you are suffering from any of the following diseases, you should not take Halovate F Cream 10gm unless your doctor advises you to do so -
Is this Halovate F Cream 10gm habit forming or addictive?
Forming a habit of Halovate F Cream 10gm has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Halovate F Cream 10gm does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Yes, Halovate F Cream 10gm is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, Halovate F Cream 10gm is not used to treat mental disorders.
Interaction between Food and Halovate F Cream 10gm
Taking Halovate F Cream 10gm with food does not cause any problems.
Interaction between Alcohol and Halovate F Cream 10gm
No research has been done on this till date. Therefore, it is not known what the effect of taking Halovate F Cream 10gm with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Halobetasol Propionate
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 369-372